Clorox Co. (CLX) Tops Q1 EPS by 5c; Reaffirms FY12 Guidance
Tweet
Share
E-mailGet Alerts CLX Hot Sheet
Join SI Premium – FREE
Clorox Co. (NYSE: CLX) reported Q1 EPS of $0.98, $0.05 better than the analyst estimate of $0.93. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.29 billion.
Reaffirms FY12 outlook.
Reaffirms FY12 outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
